NORD’s Rare Diseases and Orphan Products Breakthrough Summit is the largest and most meaningful multi-stakeholder event of its kind – historically featuring over 20 speakers from the FDA, participation from over 80 patient organizations and the Pharma/Biotech industry’s foremost experts in orphan product innovation, investment and commercialization.
The 2016 Breakthrough Summit is your opportunity to collaborate with the top leaders from the FDA, NIH, industry, patient groups, payers and research institutions to address the progress and innovations in rare disease diagnosis, treatment, patient engagement and market access of orphan products.
-Research Nurse III, Cincinatti Children’s Hospital Medical Center
-ECD Global Alliance
-Director of Research, Hemophilia Federation of America
-Director of Support Groups, CSRF
-Senior Director , Medical Affairs, Cytokinetics, Inc.
-President & CEO, EDSers United
2016 General Inquiries
2016 Sponsorship Inquiries